General information

Announcements(1)

Program

Sessions

Search presentations

Timetable

Tue. Mar 10, 2026

Wed. Mar 11, 2026

Thu. Mar 12, 2026

web_header_en.png

web_icon_ja.png

Change account information such as the email address and password on the account setting screen common to Confit.

Login required to view

Password required to view

Presentation Information

Session Details

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

Program Type

企画

Profile management

Announcements

Bookmark

Download PDF for print

Analysis of the arrhythmogenic properties of anticancer drugs using human iPS-derived cardiomyocyte sheets: comparison with multichannel blockers

Both congenital and acquired factors are variously involved in the pathogenesis of intractable arrhythmias and cardiomyopathies. Genetic mutations in ion channels and contraction-related proteins are representative of congenital factors, while acquired factors such as therapeutic drugs and lifestyles further increase disease risk. Identification of individual molecular and electrophysiological mechanisms underlying these pathological drivers can help identify the tipping point for disease onset. This symposium will highlight studies on gene mutations linked to early repolarization syndrome, which causes fatal arrhythmias; mechanism of drug-induced arrhythmias; mathematical modeling of the pathophysiology of cardiomyocytes; and related drug discovery efforts. This approach will provide an integrated understanding of cardiac dysfunction and advance the development of personalized, clinically applicable therapies.

Towards the development of personalized therapy strategies based on the pathological analyses of intractable arrhythmias and cardiomyopathies

The 103rd Annual Meeting of The Physiological Society of Japan

Presentation Information

[1S03a-01]Analysis of the arrhythmogenic properties of anticancer drugs using human iPS-derived cardiomyocyte sheets: comparison with multichannel blockers

Keywords:

Password required to view

Comment